[1] |
中华人民共和国卫生部. 《中国出生缺陷防治报告(2012)》问答[J]. 中国实用乡村医生杂志, 2012, 19(20):3-5.
|
[2] |
Bell CJ, Dinwiddie DL, Miller NA, et al. Carrier testing for severe childhood recessive diseases by next-generation sequencing[J]. Sci Transl Med, 2011, 3(65):65ra4. doi: 10.1126/scitranslmed.3001756.
|
[3] |
庄彩霞. 全国多中心早孕期11种单基因病携带者筛查[D]. 北京: 北京协和医学院, 2019.
|
[4] |
Richards S, Aziz N, Bale S, et al. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology[J]. Genet Med, 2015, 17(5):405-424. doi: 10.1038/gim.2015.30.
pmid: 25741868
|
[5] |
Zhao S, Xiang J, Fan C, et al. Pilot study of expanded carrier screening for 11 recessive diseases in China: results from 10,476 ethnically diverse couples[J]. Eur J Hum Genet, 2019, 27(2):254-262. doi: 10.1038/s41431-018-0253-9.
pmid: 30275481
|
[6] |
Grody WW, Thompson BH, Gregg AR, et al. ACMG position statement on prenatal/preconception expanded carrier screening[J]. Genet Med, 2013, 15(6):482-483. doi: 10.1038/gim.2013.47.
pmid: 23619275
|
[7] |
Chen Y, Wang Z, Jiang Y, et al. Biallelic p.V37I variant in GJB2 is associated with increasing incidence of hearing loss with age[J]. Genet Med, 2022, 24(4):915-923. doi: 10.1016/j.gim.2021.12.007.
|
[8] |
Loeber JG. Neonatal screening in Europe; the situation in 2004[J]. J Inherit Metab Dis, 2007, 30(4):430-438. doi: 10.1007/s10545-007-0644-5.
pmid: 17616847
|
[9] |
National Institutes of Health Consensus Development Panel. National Institutes of Health Consensus Development Conference Statement: phenylketonuria: screening and management, October 16-18, 2000[J]. Pediatrics, 2001, 108(4):972-982. doi: 10.1542/peds.108.4.972.
pmid: 11581453
|
[10] |
Gu X, Wang Z, Ye J, et al. Newborn screening in China: phenylketonuria, congenital hypothyroidism and expanded screening[J]. Ann Acad Med Singap, 2008, 37(< W>12 Suppl):107-114.
|
[11] |
Shi XT, Cai J, Wang YY, et al. Newborn screening for inborn errors of metabolism in mainland china: 30 years of experience[J]. JIMD Rep, 2012, 6:79-83. doi: 10.1007/8904_2011_119.
|
[12] |
王兴, 郝胜菊, 陈丕亮, 等. 甘肃省56万例新生儿苯丙酮尿症筛查结果分析[J]. 国际检验医学杂志, 2015(24):3588-3590. doi: 10.3969/j.issn.1673-4130.2015.24.034.
|
[13] |
毛新梅, 马晓燕, 李宏艳, 等. 宁夏回族自治区新生儿疾病筛查现状调查[J]. 中国妇幼保健, 2012, 27(36):5988-5990.
|
[14] |
王惠珍, 徐发亮, 陈舒清, 等. 青海省115524例不同民族新生儿疾病筛查结果分析[J]. 中国妇幼保健, 2014, 29(29):4804-4806. doi: 10.7620/zgfybj.j.issn.1001-4411.2014.29.45.
|
[15] |
Xiang L, Tao J, Deng K, et al. Phenylketonuria incidence in China between 2013 and 2017 based on data from the Chinese newborn screening information system: a descriptive study[J]. BMJ Open,2019, 9(8):e031474. doi: 10.1136/bmjopen-2019-031474.
|
[16] |
闫有圣, 姚凤霞, 郝胜菊, 等. 中国人群中苯丙酮尿症患者苯丙氨酸羟化酶基因大片段缺失突变分析[J]. 中华医学杂志, 2016, 96(14):1097-1102. doi: 10.3760/cma.j.issn.0376-2491.2016.14.007.
|
[17] |
Elborn JS. Cystic fibrosis[J]. Lancet, 2016, 388(10059):2519-2531. doi: 10.1016/S0140-6736(16)00576-6.
pmid: 27140670
|
[18] |
Hoogerwaard EM, Bakker E, Ippel PF, et al. Signs and symptoms of Duchenne muscular dystrophy and Becker muscular dystrophy among carriers in The Netherlands: a cohort study[J]. Lancet, 1999, 353(9170):2116-2119. doi: 10.1016/s0140-6736(98)10028-4.
pmid: 10382696
|
[19] |
Haque IS, Lazarin GA, Kang HP, et al. Modeled Fetal Risk of Genetic Diseases Identified by Expanded Carrier Screening[J]. JAMA, 2016, 316(7):734-742. doi: 10.1001/jama.2016.11139.
pmid: 27533158
|